Insider Buying: Inhibrx Biosciences (NASDAQ:INBX) Director Purchases $500,000.00 in Stock
Inhibrx Biosciences, Inc. (NASDAQ:INBX – Get Free Report) Director Jon Kayyem bought 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 23rd. The shares were purchased at an average cost of $100.00 per share, with a total value of $500,000.00. Following the acquisition, the director directly owned 434,360 shares of […]
23 Sep 19:10 · The Cerbat Gem